硫酶
代谢性酸中毒
医学
内分泌学
内科学
代谢紊乱
酮体
新陈代谢
过氧化物酶体
受体
作者
Toshiyuki Fukao,Hideo Sasai,Yuka Aoyama,Hiroki Otsuka,Yasuhiko Ago,Hideki Matsumoto,Elsayed Abdelkreem
标识
DOI:10.1038/s10038-018-0524-x
摘要
Beta-ketothiolase (mitochondrial acetoacetyl-CoA thiolase, T2) deficiency (OMIM #203750, *607809) is an inborn error of metabolism that affects isoleucine catabolism and ketone body metabolism. This disorder is clinically characterized by intermittent ketoacidotic crises under ketogenic stresses. In addition to a previous 26-case series, four series of T2-deficient patients were recently reported from different regions. In these series, most T2-deficient patients developed their first ketoacidotic crises between the ages of 6 months and 3 years. Most patients experienced less than three metabolic crises. Newborn screening (NBS) for T2 deficiency is performed in some countries but some T2-deficient patients have been missed by NBS. Therefore, T2 deficiency should be considered in patients with severe metabolic acidosis, even in regions where NBS for T2 deficiency is performed. Neurological manifestations, especially extrapyramidal manifestations, can occur as sequelae to severe metabolic acidosis; however, this can also occur in patients without any apparent metabolic crisis or before the onset of metabolic crisis.
科研通智能强力驱动
Strongly Powered by AbleSci AI